Chapter 1. Market Scope and Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genetic Testing Market, by Type
1.4.2 North America Genetic Testing Market, by Technology
1.4.3 North America Genetic Testing Market, by Application
1.4.4 North America Genetic Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Genetic Testing Market by Type
3.1 North America Predictive and Presymptomatic Testing Market by Country
3.2 North America Carrier Testing Market by Country
3.3 North America Prenatal and Newborn Testing Market by Country
3.4 North America Diagnostic Testing Market by Country
3.5 North America Pharmacogenomic Testing Market by Country
3.6 North America Other Types Genetic Testing Market by Country
Chapter 4. North America Genetic Testing Market by Technology
4.1 North America Cytogenetic Testing Market by Country
4.2 North America Biochemical Testing Market by Country
4.3 North America Molecular Testing Market by Country
Chapter 5. North America Genetic Testing Market by Application
5.1 North America Cancer Diagnosis Market by Country
5.2 North America Genetic Disease Diagnosis Market by Country
5.3 North America Cardiovascular Disease Diagnosis Market by Country
5.4 North America Other Applications Market by Country
Chapter 6. North America Genetic Testing Market by Country
6.1 USA Genetic Testing Market
6.1.1 USA Genetic Testing Market by Type
6.1.2 USA Genetic Testing Market by Technology
6.1.3 USA Genetic Testing Market by Application
6.2 Canada Genetic Testing Market
6.2.1 Canada Genetic Testing Market by Type
6.2.2 Canada Genetic Testing Market by Technology
6.2.3 Canada Genetic Testing Market by Application
6.3 Mexico Genetic Testing Market
6.3.1 Mexico Genetic Testing Market by Type
6.3.2 Mexico Genetic Testing Market by Technology
6.3.3 Mexico Genetic Testing Market by Application
6.4 Rest of North America Genetic Testing Market
6.4.1 Rest of North America Genetic Testing Market by Type
6.4.2 Rest of North America Genetic Testing Market by Technology
6.4.3 Rest of North America Genetic Testing Market by Application
Chapter 7. Company Profiles
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research and Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research and Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research and Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research and Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research and Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research and Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research and Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research and Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
Unique Offerings 
